Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  _______________ FORM 8-K  _______________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report:  May 25, 2023 (Date of earliest event reported)  _______________ TENET HEALTHCARE CORP ORATION (Exact name of Registrant as specified in its charter)   Nevada   1-7293   95-2557091 (State of Incorporation)   (Commission File Number)   (IRS Employer Identification Number) 14201 Dallas Parkway Dallas , Texas   75254 (Address of principal executive offices, including zip code) ( 469 ) 893-2200 (Registrant’s telephone number, including area code)   _______________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.05 par value THC New York Stock Exchange 6.875% Senior Notes due 2031 THC31 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).     Emerging Growth Company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.      ☐ Item 5.07. Submission of Matters to a Vote of Security Holders. The 2023 Annual Meeting of Shareholders (the “Annual Meeting”) of Tenet Healthcare Corporation (the “Company”) was held on May 25, 2023 . Below are the final voting results from the meeting. 1.    The Company’s shareholders elected the following directors to serve on the Company’s Board of Directors, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected or qualified, whichever is later, or until the director’s earlier resignation or removal: FOR AGAINST ABSTAIN BROKER NON-VOTES J. Robert Kerrey 83,535,834  2,527,226  514,682  6,815,599  James L. Bierman 85,146,732  922,183  508,827  6,815,599  Richard W. Fisher 85,044,275  1,026,111  507,356  6,815,599  Meghan M. FitzGerald 84,827,178  1,243,901  506,663  6,815,599  Cecil D. Haney 85,137,286  933,335  507,121  6,815,599  Christopher S. Lynch 85,082,827  986,640  508,275  6,815,599  Richard J. Mark 85,083,075  987,427  507,240  6,815,599  Tammy Romo 84,908,989  1,161,247  507,506  6,815,599  Saumya Sutaria 85,664,645  401,556  511,541  6,815,599  Nadja Y. West 85,139,884  929,376  508,482  6,815,599  2.    The Company’s shareholders approved, on an advisory basis, the Company’s executive compensation: FOR AGAINST ABSTAIN BROKER NON-VOTES 81,530,105 4,617,910 429,727 6,815,599 3.    Votes regarding the approval, on an advisory basis, of the frequency of future advisory votes on the Company’s executive compensation were as follows: ONE YEAR TWO YEARS THREE YEARS ABSTAIN BROKER NON-VOTES 84,450,639 40,680 2,057,781  28,642 6,815,599 Based on the voting result at the Annual Meeting, the Company’s Board of Directors has determined to provide for a shareholder advisory vote on executive compensation on an annual basis. 4.     The Company’s shareholders approved the ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accountants for the year ending December 31, 2023: FOR AGAINST ABSTAIN BROKER NON-VOTES 92,610,717 742,949 39,675 — 5.     The shareholder proposal requesting a report on patients’ right to access abortion in emergencies did not pass FOR AGAINST ABSTAIN BROKER NON-VOTES 7,449,831 77,442,867 1,685,044 6,815,599 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TENET HEALTHCARE CORPORATION Date: May 25, 2023 By: /s/ T HOMAS A RNST Name: Thomas Arnst Title: Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary